CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)
Close on Nov 17, 2026Market cap $364.00MP/E –Yield –
CorMedix price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CorMedix's price to book ratio was 0.9× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.9× to 12.0×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −1.5 |
| 2025 | Dec 31, 2025 | 2.4× | −5.6 |
| 2024 | Dec 31, 2024 | 8.0× | +5.5 |
| 2023 | Dec 29, 2023 | 2.5× | −0.6 |
| 2022 | Dec 30, 2022 | 3.1× | +0.6 |
| 2021 | Dec 31, 2021 | 2.5× | −4.3 |
| 2020 | Dec 31, 2020 | 6.8× | +0.3 |
| 2019 | Dec 31, 2019 | 6.5× | −285.4 |
| 2018 | Jul 31, 2018 | 291.9× | +275.8 |
| 2017 | Dec 29, 2017 | 16.0× | +3.0 |
| 2016 | Dec 30, 2016 | 13.0× | +3.1 |
| 2015 | Dec 31, 2015 | 9.9× | −28.4 |
| 2014 | Dec 31, 2014 | 38.2× | +7.2 |
| 2012 | Jul 31, 2012 | 31.0× | +9.4 |
| 2011 | Dec 30, 2011 | 21.6× | – |
See a number that looks wrong?